X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/10/2861110/0/en/Pharvaris-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/10/2861109/0/en/Pharvaris-Appoints-David-Nassif-J-D-as-Chief-Financial-Officer.html
https://www.globenewswire.com/news-release/2024/04/04/2857613/0/en/Pharvaris-to-Present-Deucrictibant-Clinical-Data-at-the-CIIC-Spring-2024-Conference.html
https://www.globenewswire.com/news-release/2024/03/18/2847642/0/en/Pharvaris-Announces-Phase-3-Clinical-Study-Design-for-Recently-Initiated-RAPIDe-3-Study-and-Presents-Quality-of-Life-Improvement-and-Caregiver-Behavior-Data-at-Two-Recent-HAE-Congr.html
https://www.globenewswire.com//news-release/2024/03/06/2841228/0/en/Pharvaris-to-Present-Deucrictibant-Clinical-Data-at-Upcoming-Congresses.html
https://www.globenewswire.com//news-release/2024/03/05/2840256/0/en/Pharvaris-to-Participate-in-the-Leerink-Global-Biopharma-Conference-2024.html
https://www.globenewswire.com//news-release/2024/02/22/2833499/0/en/Positive-Results-from-CHAPTER-1-Phase-2-Study-of-Deucrictibant-for-the-Prophylactic-Treatment-of-HAE-Attacks-to-be-Presented-at-AAAAI-2024-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/16/2830679/0/en/Pharvaris-Announces-Extraordinary-Meeting-of-Shareholders.html
https://www.globenewswire.com//news-release/2024/01/26/2817816/0/en/Pharvaris-to-Present-at-the-WSAAI-Annual-Meeting-2024.html
https://www.fiercebiotech.com/biotech/fda-lifts-remaining-hold-pharvaris-hae-drug-clearing-path-phase-3
Market Place
Share 
